Back

Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.

26 August 2018 (11:15 - 11:30)
Organised by:
Congress Presentation Part of: Outcome of coronary stenting up to 10 years Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

5 More presentations in this session

Presentation thumbnail
10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Differential effectiveness of drug-coated balloon vs. drug-eluting stent for bare-metal or drug-eluting stent restenosis: a primary prespecified subanalysis from the DAEDALUS study.
Doctor D. Giacoppo (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Up to 10-year outcome after simple crossover stenting in left main without strut opening over ostial circumflex artery
Doctor Y. Cho (Daegu, KR)
Abstract
Presentation thumbnail
Prognosis of biodegradable polymer drug-eluting stents versus second-generation durable polymer drug-eluting stents in acute myocardial infarction patients following percutaneous coronary intervention
Doctor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness analysis of increased use of percutaneous coronary intervention in acute coronary syndrome patients from 6 European countries.
Doctor I. Roman Degano (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Outcome of coronary stenting up to 10 years

The Event

Event poster

ESC Congress 2018

26 August 2018 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of percutaneous coronary intervention on improvement of left ventricular ejection fraction among chronic coronary syndrome patients with left ventricular systolic dysfunction
thumbnail
Congress Presentation
Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Percutaneous coronary intervention versus optimal medical therapy for chronic total occlusion: an updated meta-analysis of randomized controlled trials comparing clinical and health status outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources